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RESEARCH FOCUS: Main focus for the last 2.5 years (including the present 12-month 
no-cost extension) has been to complete biochemical and structural characterization of 
the organomercurial lyase (MerB). This was the 2nd major aim of the original proposal. 
Mr. Keith Pitts, graduate student, remains the mainstay of this work. Dr. Andreas Heltzel 
left the project in Dec 1999 to join a biotech firm in his native Germany. 
TECHNICAL PROGRESS: 
A. Cellular Location of MerB and its Relationship to MerA (Keith Pitts) 
The celldar location of all mer proteins except MerB had previously been determined. 
Since MerB lacks a typical signal sequence, it was assumed to be a cytosolic protein. 
However, we now know there are several classes of proteins lacking classical signal 
sequences that are nonetheless exported from the cytosol by Sec-independent 
mechanisms. Moreover, it was not obvious how the same set of transport proteins 
(MerTP and C) could take up the small metallic ion HgOI) as well as the several bulky 
organomercurials to which MerB confers resistance. 
DISCLAIMER 
 
This report was prepared as an account of work sponsored by an 
agency of the United States Government.  Neither the United States 
Government nor any agency Thereof, nor any of their employees, 
makes any warranty, express or implied, or assumes any legal 
liability or responsibility for the accuracy, completeness, or 
usefulness of any information, apparatus, product, or process 
disclosed, or represents that its use would not infringe privately 
owned rights.  Reference herein to any specific commercial product, 
process, or service by trade name, trademark, manufacturer, or 
otherwise does not necessarily constitute or imply its endorsement, 
recommendation, or favoring by the United States Government or any 
agency thereof.  The views and opinions of authors expressed herein 
do not necessarily state or reflect those of the United States 
Government or any agency thereof. 
DISCLAIMER 
 
Portions of this document may be illegible in 
electronic image products.  Images are produced 
from the best available original document. 
 
To resolve this question we osmotically shocked E. coZi cells carrying the entire broad- 
spectrum mer operon on plasmid R83 1 b or on small plasmids carrying cloned derivatives 
of MerB. Using both antibody and enzyme assays, we found that MerB partitioned with 
MerA, the mercuric reductase, and chromosomally-encoded Lac2 (both previously 
known to be cytosolic), but not with MerP (known to be periplasmic) (Pitts, Zeng, & 
Summers, revised version submitted to Appl. Environ. Microbiol. 12 Sept 00). The 
structural implication of this observation is that the 4 cysteine residues of MerB are very 
likely in the thiol form, and do not serve as disulfide bonds in the protein. 
Upon learning that MerA and MerB are located in the same cellular compartment, we 
used the homobifunctional crosslinking agent DSS to ask whether there is any stable 
association between them which might channel the toxic MerB reaction product, Hg(II), 
directly to the reductase. In Vitro DSS crosslinked MerA to itself (as expected, it is 
known to be a dimer) but did not crosslink MerB to itself (as expected, it is known to be 
a monomer). And MerB did not crosslink to MerA under conditions we used in which 
even the faint crosslinks of the transcriptional activator MerR to RNA polymerase can 
be detected(Kulkami, 1999 #2215). 
Thus, we have established that MerB is a cytosolic enzyme whose cysteines are not 
involved in disulfide bonds, and it does not form a stable quaternary complex with 
MerA. 
B. Optimized in vitro assay of MerB (Keith Pitts) 
Earlier work on the enzyme {Begley, 1986 #30; Begley, 1986 #31} used a general but 
relatively unwieldy gas chromatography assay and we have expIored spectrophotometric 
assay alternatives. The first of these followed the decrease in absorbance of p- 
hydroxymercuribenzoate (PHMB) at 240 nm and was adequate for initial activity 
determinations during purification. However, the high extinction coefficient of PJ3MB at 
this wavelength and the known high Km of MerB (Begley, 1986 #30; Begley, 1986 
#3 1 made this assay unsuitable for kinetic work. 
We have now developed an assay based on the Hg-thiolate charge transfer chromophore 
at c a  300 nm. We have established conditions in which the extinction coefficient for 
RHg-Cys (where R = p-hydroxy benzoic acid) is ca. 100-fold lower than that for Cys- 
Hg-Cys. The increase in absorbance at 300 nm when H g O  is released from PHMB by 
MerB is linear over the range of 20 pM to 1000 pM (raging fiom 0.1 to 1.8 AUFS ), 
quite adequate for kinetic work. This assay is also generalizable to any organomercurial 
with a low Hg-thiolate extinction coefficient compared to the Cys-Hg-Cys extinction 
coefficient; thus, we will be able to use it to assess substrate specificity for a much larger 
variety of organomercurials (Pitts, Zeng, & Summers, revised version submitted to Appl. 
Environ. Microbiol. 12 Sept 00). 
C. Site-Directed Mutagenesis of MerB (Keith Pitts) 
A preliminary report (Moore, 1990 #1219) had indicated that altering any of MerB's 
cysteines resulted in loss of the organomercurial resistance phenotype, a surprising 
finding since only 3 of the 4 cysteines are conserved in both Gram positive and Gram 
negative versions of the protein. For a thorough study of the role(s) of Cys residues in 
MerB, we made both Ala and Ser substitutions for each of the 4 C y s  residues. All 
mutants express protein as well as the wildtype and the protein is predominantly in the 
soluble form except for C117A and C117S, both of which form inclusion bodies (even 
under leaky, low temperature expression conditions). Cysll7 is one of the 3 conserved 
residues and these data suggest that its presence is important for normal folding of the 
protein, an unexpected result since its cytosolic location makes it unlikely that MerB's 
cysteines are involved in disulfide bonds. 
In vitro enzyme assays completed so far indicate that C96A and C159S mutants 
completely lack activity. C160A and C160S retain 20% and 33% of wildtype activity, 
respectively. Enzymatic activity of the C 1 17 mutant proteins could not be assessed 
because of their tendency to form insoluble precipitates. 
the three most highly conserved cysteines (96,117, and 159) having important roles in 
catalysis. C160 appears to have a less significant, but not negligible, role. Since the 
substitutions we made were the same ones evaluated phenotypically by others previously 
{Moore, 1990 #1219}, our enzyme data indicate that loss of even 7040% of activity 
results in a loss of resistance to phenylmercuric acetate. This bodes well for being able to 
obtain and assess structurally interesting proteins of intermediate function via the genetic 
screens and selections proposed originally. 
These data are consistent with 
D. Chemical characterization of the reactivity of thiol groups in MerB (Keith Pitts) 
All of the mercury resistance proteins use cysteine residues to interact with mercury 
compounds. Unlike other proteins, &e various mer proteins are not inhibited by Hg, but 
actually carry out enzymatic processes with it. Thus, the reactivity of thiols in MerB is of 
paramount importance in understanding and modifying its enzymatic mechanism. 
Crosslinking MerB with dibromobimane which becomes fluorescent when it reacts with 
adjacent thiols (within c a  8 A of each other) resulted in fluorescent derivatives of MerB 
itself and of at least one of its tryptic fragments. These observations indicate that at least 
two of the cysteines in the protein monomer are within 8 8, of each other. 
Dibromobimane is currently being applied to the cysteine mutant preteins in order to sort 
out which cysteines is involved in the intra-monomer dibromobimane cross-links. These 
data on the steric accessibility of MerB's cysteines will provide useful constraints for 
interpretation of NMR data (see below), Additional current work with wildtype and 
the cysteine mutants is assessing their reaction patterns with iodoacetamide in the 
presence and absence of organomercurial substrate. We expect to complete a manuscript 
on these chemical modifications of the wildtype and mutant proteins during early winter. 
E. Determination of the solution structure of MerB by heteronuclear NMR 
(collaboration with Jim Omichinski in Dept. of Biochemistry). 
This subproject which is supported by a special structural biology supplement to the 
original grant (awarded in May 1999) has resulted in the production of hundreds of 
milligrams of pure wildtype MerB protein substituted with 15N or with 13C or both. The 
protein has a very highly resolved proton spectrum, consistent with a very stable fold. 
Jim and post-doc Dr. Paola di Liello have completed acquisition of 80% of the 
necessary NMR data for solving the solution structure of the protein. Data have also 
been taken on all of the cysteine mutant proteins, allowing unique assignment of cysteine 
cross-peaks. Remaining residue assignment is currently underway as the final 
spectroscopic data are being accumulated for both the wildtype and mutant proteins. 
Some data have also been taken with various organomercurial substrates added and there 
is evidence for an allosteric change in MerB upon interaction with all substrates. 
We expect to be able to submit for publication a manuscript on the NMR solution 
structure of MerB by late spring, 20001. In order to complete this part of the project, we 
have applied for a supplement on our newer, related DOE grant from the NABIR 
program on the metalloregulator, MerR. This application is pending. 
